Valeant Pharmaceuticals International Inc
featured
Take a look at some of Friday's midday movers:
» Read More
More
-
NEW YORK-- Shares of Valeant Pharmaceuticals International Inc. spiked up Friday afternoon after a report said it might soon buy eye care company Bausch& Lomb Inc. Both comments wouldn't comment.
-
NEW YORK-- A look at the 10 biggest volume gainers on New York Stock Exchange at the close of trading:. Abercrombie& Fitch Co.: Approximately 9,422,600 shares changed hands, a 392.1 percent increase over its 65- day average volume. The shares fell $4.35 or 8.0 percent to $50.02.
-
NEW YORK-- Shares of Valeant Pharmaceuticals International Inc. spiked up Friday afternoon after a report said it might soon buy eye care company Bausch& Lomb Inc. Both comments wouldn't comment.
-
May 24- Ista Pharmaceuticals Inc pleaded guilty on Friday to charges it used kickbacks and improper marketing to boost sales of a drug meant to treat eye pain and agreed to pay $33.5 million to settle criminal and civil liability, the U.S. Department of Justice said.
-
NEW YORK, May 24- Canada's Valeant Pharmaceuticals International is nearing a deal to acquire eye care company Bausch& Lomb Holdings Inc from Warburg Pincus LLC for about $9 billion, a person familiar with the matter said on Friday.
-
NEW YORK-- A look at the 10 biggest percentage gainers on New York Stock Exchange at 1 p.m.:. Infoblox Inc. rose 12.8 percent to $24.82. Valeant Pharmaceuticals International rose 11.4 percent to $83.16.
-
NEW YORK, May 24- Canada's Valeant Pharmaceuticals International is nearing a deal to acquire eye care company Bausch& Lomb from private equity owner Warburg Pincus LLC for about $9 billion, a person familiar with the matter said on Friday. The person requested anonymity because the matter is not public.
-
Generic drugmaker Actavis will buy specialty pharmaceuticals company Warner Chilcott in a stock deal valued at about $8.5 billion.
-
May 20- Generic drugmaker Actavis Inc, which has been the subject of intense takeover speculation, said on Monday that it had struck a deal to buy specialty pharmaceuticals company Warner Chilcott Plc for $8.5 billion in stock.
-
The Parsippany, N.J., company's stock had already climbed about 16 percent since last Friday, when Actavis and Irish drugmaker Warner Chilcott PLC said that they were in early talks about a possible combination but had reached no agreement yet. Actavis shares rose 62 cents to $124.50 in premarket trading about 40 minutes ahead of Thursday's market opening.
-
Actavis received and rejected a takeover offer from Mylan last week that valued the generic drugmaker at more than $15 billion, a person familiar with the situation said.
-
May 2- Valeant Pharmaceuticals International Inc:. *Says intends to vigorously contest Anacor's claims and continues to expect to. launch the product in 2013* Source text for Eikon* Further company coverage ().
-
*TSX rises 58.35 points, or 0.47 percent, to 12,379.64. TORONTO, May 2- Financial shares pushed Canada's main stock index higher on Thursday after the European Central Bank cut interest rates and insurers Manulife Financial Corp.
-
TORONTO, May 2- Canada's main stock index was little changed on Thursday as weakness in some healthcare and material stocks after weak earnings reports offset optimism following a move by the European Central Bank to cut interest rates. The market was disappointed by results from Goldcorp Inc.
-
TORONTO, May 2- Canada's main stock index turned negative in early Thursday trade, hurt by weakness in materials and energy stocks, as well as declines in healthcare companies Catamaran Corp. The Toronto Stock Exchange's S&P/TSX composite index. was down 39.95 points, or 0.32 percent, at 12,281.34, after opening higher.
